| Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia (NCT04505254) | M.D. Anderson Cancer Center | 2020-08-25 |
| Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia (NCT04984551) | M.D. Anderson Cancer Center | 2020-08-24 |
| DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers (NCT04388852) | M.D. Anderson Cancer Center | 2020-08-20 |
| Technology-Enhanced Palliative Care for Advanced Cancer Patients (NCT04989556) | M.D. Anderson Cancer Center | 2020-08-20 |
| Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology (NCT04988009) | M.D. Anderson Cancer Center | 2020-08-20 |
| MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial (NCT04580836) | M.D. Anderson Cancer Center | 2020-08-19 |
| Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults (NCT04530487) | M.D. Anderson Cancer Center | 2020-08-19 |
| Telementoring Intervention (ECHO) for the Transformation of Professional Engagement, Practice Efficiency, and Community Building Through Team Meetings in Diagnostic Imaging Clinicians (NCT04196972) | M.D. Anderson Cancer Center | 2020-08-16 |
| Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery (NCT04560712) | M.D. Anderson Cancer Center | 2020-08-12 |
| An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response (NCT04796818) | M.D. Anderson Cancer Center | 2020-08-12 |
| An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy (NCT04589624) | M.D. Anderson Cancer Center | 2020-08-12 |
| Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma (NCT04523818) | M.D. Anderson Cancer Center | 2020-08-11 |
| Target Muscle Re-innervation and Regenerative Peripheral Nerve Interfaces Alone and in Combination for the Treatment of Residual and Phantom Limb Pain in Cancer Patients Who Have Received an Amputation (NCT06840262) | M.D. Anderson Cancer Center | 2020-08-10 |
| Expressive Writing for the Management of Stress in Cancer Survivors (NCT04776941) | M.D. Anderson Cancer Center | 2020-08-07 |
| Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma (NCT04594187) | M.D. Anderson Cancer Center | 2020-08-07 |
| Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma (NCT04189757) | M.D. Anderson Cancer Center | 2020-08-07 |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery (NCT04169763) | M.D. Anderson Cancer Center | 2020-08-07 |
| Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial (NCT04575935) | M.D. Anderson Cancer Center | 2020-08-05 |
| Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer (NCT04560686) | M.D. Anderson Cancer Center | 2020-08-05 |
| Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial (NCT04604509) | M.D. Anderson Cancer Center | 2020-08-04 |
| Perioperative Care in the Cancer Patient -1, ARCA-1 Study (NCT04491409) | M.D. Anderson Cancer Center | 2020-08-03 |
| Impact of Perioperative Anesthetic Management on Renal Cancer Progression. (NCT06536244) | M.D. Anderson Cancer Center | 2020-07-31 |
| Electroencephalographic Changes Under General Anesthesia in Patients With Gynecologic Cancers With and Without History of Chemotherapy (NCT04593550) | M.D. Anderson Cancer Center | 2020-07-31 |
| Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) (NCT04200534) | M.D. Anderson Cancer Center | 2020-07-31 |
| Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT04169737) | M.D. Anderson Cancer Center | 2020-07-29 |
| ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor (NCT04216563) | M.D. Anderson Cancer Center | 2020-07-29 |
| Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia (NCT04565665) | M.D. Anderson Cancer Center | 2020-07-29 |
| Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer (NCT04090567) | M.D. Anderson Cancer Center | 2020-07-28 |
| Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer (NCT04228042) | M.D. Anderson Cancer Center | 2020-07-28 |
| Magrolimab, Azacitidine, and Venetoclax for the Treatment of Acute Myeloid Leukemia (NCT04435691) | M.D. Anderson Cancer Center | 2020-07-28 |
| Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma (NCT04432506) | M.D. Anderson Cancer Center | 2020-07-27 |
| Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations (NCT04493138) | M.D. Anderson Cancer Center | 2020-07-21 |
| Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome (NCT04487106) | M.D. Anderson Cancer Center | 2020-07-21 |
| Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas (NCT04074746) | M.D. Anderson Cancer Center | 2020-07-18 |
| Patient and Caregiver Attitudes and Beliefs Regarding Prescription of Intranasal Naloxone Spray for Opioid Overdose (NCT04129138) | M.D. Anderson Cancer Center | 2020-07-18 |
| Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines (NCT02962661) | M.D. Anderson Cancer Center | 2020-07-18 |
| Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma (NCT04404088) | M.D. Anderson Cancer Center | 2020-07-16 |
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02390635) | M.D. Anderson Cancer Center | 2020-07-15 |
| Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program (NCT04557709) | M.D. Anderson Cancer Center | 2020-07-13 |
| The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and Survivors (NCT04551378) | M.D. Anderson Cancer Center | 2020-07-13 |
| Effect of the COVID-19 Public Health Crisis on the Mental Health and Physical Well-Being of Cancer Patients, the Coping With COVID Study (NCT04652505) | M.D. Anderson Cancer Center | 2020-07-13 |
| Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy (NCT04560673) | M.D. Anderson Cancer Center | 2020-07-10 |
| Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations (NCT04216472) | M.D. Anderson Cancer Center | 2020-07-10 |
| Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma (NCT04407247) | M.D. Anderson Cancer Center | 2020-07-09 |
| Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma (NCT04553757) | M.D. Anderson Cancer Center | 2020-07-08 |
| Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator Training (NCT04832698) | M.D. Anderson Cancer Center | 2020-07-08 |
| Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines (NCT04595422) | M.D. Anderson Cancer Center | 2020-07-02 |
| NBTXR3 Activated by Radiation Therapy for the Treatment of Locally Advanced or Borderline-Resectable Pancreatic Cancer (NCT04484909) | M.D. Anderson Cancer Center | 2020-07-01 |
| CD19-Specific T Cells Post AlloSCT (NCT03579888) | M.D. Anderson Cancer Center | 2020-06-26 |
| Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy (NCT04645680) | M.D. Anderson Cancer Center | 2020-06-24 |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer (NCT03203525) | M.D. Anderson Cancer Center | 2020-06-23 |
| Identification of Surgical Management of Lymph Node Basins and Surgical Practice Patterns Among Sarcoma Surgeons (NCT04553744) | M.D. Anderson Cancer Center | 2020-06-22 |
| Osimertinib in Combination With Alisertib or Sapanisertib for the Treatment of Osimertinib-Resistant EGFR Mutant Stage IIIB or IV Non-Small Cell Lung Cancer (NCT04479306) | M.D. Anderson Cancer Center | 2020-06-18 |
| Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic (NCT04482647) | M.D. Anderson Cancer Center | 2020-06-17 |
| Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia (NCT04533919) | M.D. Anderson Cancer Center | 2020-06-16 |
| Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic (NCT04474301) | M.D. Anderson Cancer Center | 2020-06-11 |
| Assessment of What Patients and Healthcare Providers Value (NCT04483349) | M.D. Anderson Cancer Center | 2020-06-11 |
| Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic (NCT04500600) | M.D. Anderson Cancer Center | 2020-06-11 |
| Repeat or Single Quadratus Lumborum Block for the Reduction of Opioid Prescriptions After Surgery in Retroperitoneal Sarcoma Patients ("RESQU-SARC" Trial) (NCT04189783) | M.D. Anderson Cancer Center | 2020-06-08 |
| Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma (NCT03282396) | M.D. Anderson Cancer Center | 2020-06-08 |
| Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics (NCT03862079) | M.D. Anderson Cancer Center | 2020-06-01 |
| Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT04216524) | M.D. Anderson Cancer Center | 2020-05-29 |
| Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial (NCT04311723) | M.D. Anderson Cancer Center | 2020-05-27 |
| Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (NCT04128748) | M.D. Anderson Cancer Center | 2020-05-27 |
| Well-being in Cancer Patients With Neuropathy During COVID-19 Who Participated in Prior Clinical Trials (NCT04650178) | M.D. Anderson Cancer Center | 2020-05-26 |
| Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT04458610) | M.D. Anderson Cancer Center | 2020-05-26 |
| Communication Skills to Build a Diverse Biomedical Workforce (NCT05048290) | M.D. Anderson Cancer Center | 2020-05-19 |
| Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce (NCT04491292) | M.D. Anderson Cancer Center | 2020-05-18 |
| Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia (NCT04188405) | M.D. Anderson Cancer Center | 2020-05-17 |
| Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors (NCT04447222) | M.D. Anderson Cancer Center | 2020-05-12 |
| Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting (NCT04128501) | M.D. Anderson Cancer Center | 2020-05-05 |
| Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) (NCT04513990) | M.D. Anderson Cancer Center | 2020-04-09 |
| Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy (NCT04870853) | M.D. Anderson Cancer Center | 2020-04-02 |
| Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant (NCT04317781) | M.D. Anderson Cancer Center | 2020-03-27 |
| Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring (NCT05054296) | M.D. Anderson Cancer Center | 2020-03-23 |
| MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated Gliomas (NCT04373720) | M.D. Anderson Cancer Center | 2020-03-20 |
| Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers (NCT04171219) | M.D. Anderson Cancer Center | 2020-03-19 |
| Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer (NCT04220775) | M.D. Anderson Cancer Center | 2020-03-18 |
| Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors (NCT04266912) | M.D. Anderson Cancer Center | 2020-03-17 |
| Effect of Digital Health Coaching Program on Self-efficacy and Patient Reported Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia (NCT04774744) | M.D. Anderson Cancer Center | 2020-03-17 |
| Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant (NCT04022239) | M.D. Anderson Cancer Center | 2020-03-13 |
| Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer (NCT04622670) | M.D. Anderson Cancer Center | 2020-03-10 |
| Sleep Disturbances in Surgical Patients With GI Cancers: A Quantitative and Qualitative Analysis (NCT05044312) | M.D. Anderson Cancer Center | 2020-03-06 |
| Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their Partners (NCT04189770) | M.D. Anderson Cancer Center | 2020-02-26 |
| Increasing Access to Smoking Cessation and Smoke Free Home Services for Low-Income Pregnant Women in Northeast Texas (NCT05051345) | M.D. Anderson Cancer Center | 2020-02-18 |
| Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes (NCT04743466) | M.D. Anderson Cancer Center | 2020-02-13 |
| Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR (NCT05054400) | M.D. Anderson Cancer Center | 2020-02-05 |
| Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer (NCT04058964) | M.D. Anderson Cancer Center | 2020-02-01 |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas (NCT04623931) | M.D. Anderson Cancer Center | 2020-01-30 |
| Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma (NCT04310397) | M.D. Anderson Cancer Center | 2020-01-29 |
| Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia (NCT03989466) | M.D. Anderson Cancer Center | 2020-01-15 |
| Software-Aided Imaging (Morfeus) for Confirming Tumor Coverage With Ablation in Patients With Liver Tumors, the COVER-ALL Study (NCT04083378) | M.D. Anderson Cancer Center | 2020-01-10 |
| Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management (NCT04216732) | M.D. Anderson Cancer Center | 2020-01-10 |
| Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions (NCT04132843) | M.D. Anderson Cancer Center | 2020-01-10 |
| Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies (NCT05011045) | M.D. Anderson Cancer Center | 2020-01-09 |
| Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors (NCT04634617) | M.D. Anderson Cancer Center | 2020-01-09 |
| Cryoablation for the Treatment of Metastatic Cancer (NCT04150939) | M.D. Anderson Cancer Center | 2019-12-23 |
| Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam (NCT04286386) | M.D. Anderson Cancer Center | 2019-12-19 |
| Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm (NCT04140487) | M.D. Anderson Cancer Center | 2019-12-17 |
| Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer (NCT04220827) | M.D. Anderson Cancer Center | 2019-12-06 |